top of page
GBX_EVENTS_2024_womeninscience_#GBX_Staff_#CGTI_#BILS_DDIF_#MEVO
GBX Events Icon

Tanvir Tabish

Director, Early Formulation Development at AstraZeneca

Tanvir Tabish joined Astrazeneca about three months ago and is working as a Director in the Dosage Form Design and Development (DFDD) group of the company; Tanvir is currently based in Cambridge, UK. The responsibilities of the DFDD group include developing pharmaceutically stable, market competitive, user-centric biopharmaceutical dosage forms for biologics, including drug products, drug delivery systems, and delivery devices for clinical and commercial use. Prior to joining Astrazeneca, Tanvir has worked for Novartis, Takeda, Beafour Ipsen and GSK. At Takeda, Tanvir’s responsibilities included developing stable formulations for various Gene Therapy and protein-based modalities. Before Takeda, Tanvir worked as an Associate Director, for Beaufour Ipsen, and managed a trans-national Early and Pre-Formulation Development group with members based in Paris and Boston. Tanvir has extensive experience of working in the Biopharmaceutical industry having also worked, for 15 years, in the Biopharmaceutical Product Development Division of GlaxoSmithKline.

Share
  • LinkedIn
  • Youtube
  • X
  • Instagram
How we drive innovation
STORIES
MEETINGS
MEMBERS
Speakers
bottom of page